OnKure Therapeutics Inc. (OKUR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    OnKure Therapeutics Inc.

    NASDAQ: OKUR · Real-Time Price · USD
    2.71
    -0.09 (-3.21%)
    At close: Oct 03, 2025, 3:59 PM
    2.71
    0.00%
    Pre-market: Oct 06, 2025, 04:12 AM EDT

    OnKure Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 855K 655K 594K 466K 497K 485K 334K 43K n/a n/a
    Gross Profit
    		 -855K -655K -594K -466K -497K -485K -334K -43K n/a n/a
    Operating Income
    		 -71.78M -69.8M -62.63M -7.72M -23.95M -18.24M -17.16M -38.27M -17.39M -8.75M
    Interest Income
    		 2.01M 1.3M 525K 525K 525K 746K 524K 524K 524K 73K
    Pretax Income
    		 -70.2M -68.95M -62.56M -8.84M -24.35M -18.39M -17.54M -36.06M -16.86M -8.68M
    Net Income
    		 -70.2M -68.95M -62.56M -8.84M -24.35M -18.39M -17.54M -36.06M -16.86M -8.68M
    Selling & General & Admin
    		 7.8M 7.78M 5.05M -5.6M -2.1M -4.57M -4.6M 9.62M 2.35M 1.23M
    Research & Development
    		 63.77M 62.03M 57.58M 13.33M 26.05M 22.81M 21.77M 28.66M 15.04M 7.52M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 71.57M 69.8M 62.63M 7.72M 23.95M 18.24M 17.16M 38.27M 17.39M 8.75M
    Interest Expense
    		 n/a 26K 26K 26K 26K n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 71.78M 69.8M 62.63M 7.72M 23.95M 18.24M 17.16M 38.27M 17.39M 8.75M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 13.51M 13.42M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M
    Shares Outstanding (Diluted)
    		 13.51M 13.42M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M
    EPS (Basic)
    		 -5.25 -5.17 -4.69 -0.66 -1.82 -1.37 -1.31 -2.7 -1.26 -0.65
    EPS (Diluted)
    		 -5.25 -5.17 -4.69 -0.66 -1.82 -1.37 -1.31 -2.7 -1.26 -0.65
    EBITDA
    		 -60.03M -58.82M -51.71M 996K -41.74M -35.81M -34.75M -56.3M -16.65M -8.62M
    EBIT
    		 -60.82M -59.54M -52.37M 522K -42.32M -36.39M -35.31M -56.42M -16.93M -8.75M
    Depreciation & Amortization
    		 787K 723K 662K 474K 576K 583K 560K 126K 283K 128K

    Add to Watchlist